ALX Oncology Inc.
ALXO | NASDAQ
$1.66
-$0.04 (-2.35%)
At close: Sep 21, 2026, 4:00 PM ET
$1.65
-$0.01 (-0.60%)
After-hours:
Sep 21, 2026, 7:52 PM ET
Institutional Ownership
Net InflowTotal Institutions
72
Total Ownership
90.15%
Capital Flow
+$155.54M
Shares Change
+65.06M
Ownership Distribution
Institutions (90.15%)
Others (9.85%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
26
Increased Positions
45
Reduced Positions
10
Closed Positions
12
New (26)
Increased (45)
Reduced (10)
Closed (12)
Options Sentiment & Activity
bullishPut/Call Ratio
0.386
Call Flow
51,100
Put Flow
19,700
Calls (72%)
Puts (28%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Point72 Asset Management LP | 0.04% +103.27% | < 0.01% | 41.1K | 79.72K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Ra Capital Management, L.p. | 12.44% +100.00% | 0.28% +100.00% | 13.01M +100.00% | 26.09M +100.00% | |
| Tcg Crossover Management, LLC | 12.44% +100.00% | 0.75% +100.00% | 13.01M +100.00% | 26.09M +100.00% | |
| Venbio Partners LLC | 12.32% -31.84% | 9.21% +81.69% | 12.88M +32.83% | 25.83M +135.69% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove ALXO